Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Orr

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Anti-Cancer Drug Design|December 1, 1987
Synthesis and ribonucleotide reductase inhibitory activity of analogues of 2,3-dihydro-1H-imidazo[1,2-b]pyrazole (IMPY)A J Goddard, R M Orr, J A Stock, et al.
Journal of Neurosurgical Anesthesiology|December 1, 1989
Naloxone: report of a beneficial side effectS W Krechel, R M Orr, N B Couper, et al.
Surgery, Gynecology & Obstetrics|May 1, 1983
Primary aortoduodenal fistula following radiotherapyF P Estrada, T J Tachovsky, R M Orr, et al.
BMJ Military Health|July 14, 2024
Determining cut-off scores for simulated tasks in Brazilian Air Force military personnelWillian Carrero Botta, J M Magraner, R M Orr, et al.
Journal of Medicinal Chemistry|July 1, 1988
Dinucleotide analogues as inhibitors of thymidine kinase, thymidylate kinase, and ribonucleotide reductaseL C Davies, J A Stock, S E Barrie, et al.
Biochemical Pharmacology|February 15, 1988
Inhibition of human leukaemic thymidylate kinase and L1210 ribonucleotide reductase by dinucleotides of adenosine and thymidine and their phosphonate analoguesR M Orr, L C Davies, J A Stock, et al.
British Journal of Cancer|December 1, 1996
The cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: a flow cytometric studyM G Ormerod, R M Orr, C F O'Neill, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|March 4, 2000
Induction of apoptosis by a novel copper-based anticancer compound, casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cellsA De Vizcaya-Ruiz, A Rivero-Muller, L Ruiz-Ramirez, et al.
Anticancer Research|January 1, 1996
Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumoursP M Goddard, R M Orr, M R Valenti, et al.
British Journal of Cancer|September 1, 1994
Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatinR M Orr, C F O'Neill, M C Nicolson, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Anti-Cancer Drug Design|December 1, 1987
Synthesis and ribonucleotide reductase inhibitory activity of analogues of 2,3-dihydro-1H-imidazo[1,2-b]pyrazole (IMPY)A J Goddard, R M Orr, J A Stock, et al.
Journal of Neurosurgical Anesthesiology|December 1, 1989
Naloxone: report of a beneficial side effectS W Krechel, R M Orr, N B Couper, et al.
Surgery, Gynecology & Obstetrics|May 1, 1983
Primary aortoduodenal fistula following radiotherapyF P Estrada, T J Tachovsky, R M Orr, et al.
BMJ Military Health|July 14, 2024
Determining cut-off scores for simulated tasks in Brazilian Air Force military personnelWillian Carrero Botta, J M Magraner, R M Orr, et al.
Journal of Medicinal Chemistry|July 1, 1988
Dinucleotide analogues as inhibitors of thymidine kinase, thymidylate kinase, and ribonucleotide reductaseL C Davies, J A Stock, S E Barrie, et al.
Biochemical Pharmacology|February 15, 1988
Inhibition of human leukaemic thymidylate kinase and L1210 ribonucleotide reductase by dinucleotides of adenosine and thymidine and their phosphonate analoguesR M Orr, L C Davies, J A Stock, et al.
British Journal of Cancer|December 1, 1996
The cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: a flow cytometric studyM G Ormerod, R M Orr, C F O'Neill, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|March 4, 2000
Induction of apoptosis by a novel copper-based anticancer compound, casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cellsA De Vizcaya-Ruiz, A Rivero-Muller, L Ruiz-Ramirez, et al.
Anticancer Research|January 1, 1996
Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumoursP M Goddard, R M Orr, M R Valenti, et al.
British Journal of Cancer|September 1, 1994
Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatinR M Orr, C F O'Neill, M C Nicolson, et al.
Pageof 3